![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Tsuyuki R.T.
Publisher: Adis International
ISSN: 1170-229X
Source: Drugs & Aging, Vol.16, Iss.1, 2000-01, pp. : 1-7
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
-Blockers in heart failure: who gains the most?
Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
-Blockers have a role in severe heart failure?
Inpharma, Vol. 1, Iss. 1291, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Effects of -Blockers on Neurohormonal Activation in Patients with Congestive Heart Failure
By Baran D.
Drugs, Vol. 60, Iss. 5, 2000-11 ,pp. :